Closed
Hepatitis C Medicines
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- Value
- £7,859,580.43
- Published
- 7 Oct 2026
- Deadline
- 6 Nov 2026
- Procedure
- Open procedure
- Category
- 33600000 — Pharmaceutical products
- Location
- UKL, United Kingdom
- Notice reference
- 094856-2026
Requirements summary
NHS Wales Shared Services Partnership-Procurement Services, hosted by Velindre University NHS Trust, is procuring antiviral medicines for treating Hepatitis C (HCV) for NHS Wales through an open procedure. The single lot is valued at GBP 6,549,650.36 net (GBP 7,859,580.43 gross), with a contract period from 1 May 2027 to 30 April 2029 and an option to extend by up to two years.
Key requirements
- Supply of antiviral medicines for the treatment of Hepatitis C (HCV) to NHS Wales
- Single lot with an estimated net value of GBP 6,549,650.36 (gross GBP 7,859,580.43)
- Contract period 1 May 2027 to 30 April 2029, with an extension option of up to 2 years (to 30 April 2031)
- Award based on cost (85%) and environmental/social value/community benefits (15%), with product quality assessed as pass/fail
- Tender submissions due by 6 November 2026 at 12:00 via the e-tender Wales portal; SMEs are eligible to bid
- Delivery to the United Kingdom; Welsh devolved regulations apply and the procurement is covered by the GPA
Similar open notices
- Generic Drugs - Oral LiquidsNHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- Generic Drugs - Oral LiquidsNHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- NHS National Framework Agreement for Macitentan & Cladribine TabletsNHS England
- Injection Equipment ParaphernaliaThe Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy ServicesUniversity Hospitals of Derby and Burton NHS Foundation Trust